These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8095698

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Severe thrombocytopenia in hantavirus-induced nephropathia epidemica.
    Latus J, Kitterer D, Segerer S, Artunc F, Alscher MD, Braun N.
    Infection; 2015 Feb; 43(1):83-7. PubMed ID: 25380569
    [Abstract] [Full Text] [Related]

  • 23. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.
    Kates DM, Sherrard DJ, Andress DL.
    Am J Kidney Dis; 1997 Dec; 30(6):809-13. PubMed ID: 9398125
    [Abstract] [Full Text] [Related]

  • 24. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC, Quach HP, Vieth R, Pang KS.
    Am J Physiol Endocrinol Metab; 2013 May 01; 304(9):E977-89. PubMed ID: 23482451
    [Abstract] [Full Text] [Related]

  • 25. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
    Vaes AMM, Tieland M, de Regt MF, Wittwer J, van Loon LJC, de Groot LCPGM.
    Clin Nutr; 2018 Jun 01; 37(3):808-814. PubMed ID: 28433267
    [Abstract] [Full Text] [Related]

  • 26. Lack of effects of 1,25- and 24,25-dihydroxy vitamin D on parathyroid hormone response to hypocalcemia in cattle.
    Voumard B, Trechsel U, Fischer JA, Blum JW.
    Metab Bone Dis Relat Res; 1984 Jun 01; 5(4):171-5. PubMed ID: 6429475
    [Abstract] [Full Text] [Related]

  • 27. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gautvik KM, Gordeladze JO.
    Biosci Rep; 1993 Feb 01; 13(1):27-39. PubMed ID: 8392394
    [Abstract] [Full Text] [Related]

  • 28. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E, Canaff L, Fox J, Hendy GN.
    Endocrinology; 1997 Jun 01; 138(6):2596-600. PubMed ID: 9165053
    [Abstract] [Full Text] [Related]

  • 29. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U, Chan JC.
    J Clin Endocrinol Metab; 1984 Apr 01; 58(4):671-5. PubMed ID: 6546575
    [Abstract] [Full Text] [Related]

  • 30. Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure.
    Akmal M, Bishop JE, Telfer N, Norman AW, Massry SG.
    J Clin Endocrinol Metab; 1986 Jul 01; 63(1):137-42. PubMed ID: 3011837
    [Abstract] [Full Text] [Related]

  • 31. 25-hydroxyvitamin D3 metabolism by isolated perfused rat kidney.
    Rosenthal AM, Jones G, Kooh SW, Fraser D.
    Am J Physiol; 1980 Jul 01; 239(1):E12-20. PubMed ID: 6249124
    [Abstract] [Full Text] [Related]

  • 32. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB.
    J Clin Endocrinol Metab; 1988 Nov 01; 67(5):876-81. PubMed ID: 3182962
    [Abstract] [Full Text] [Related]

  • 33. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
    Caravaca F, Fernández MA, Ruiz-Calero R, Cubero J, Aparicio A, Jimenez F, García MC.
    Nephrol Dial Transplant; 1998 Oct 01; 13(10):2605-11. PubMed ID: 9794568
    [Abstract] [Full Text] [Related]

  • 34. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993 Oct 01; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 35. [Calcium metabolism and the level of active metabolites of vitamin D3 in the rat serum during bone regeneration].
    Arkhapchev IuP, Sergeev IN, Spirichev VB, Blazhevich NV.
    Vopr Med Khim; 1986 Oct 01; 32(4):122-9. PubMed ID: 3020792
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
    Werder EA, Fischer JA, Illig R, Kind HP, Bernasconi S, Fanconi A, Prader A.
    J Clin Endocrinol Metab; 1978 Jun 01; 46(6):872-9. PubMed ID: 233700
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Vitamin D metabolites and bone mineralization in man.
    Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A.
    J Clin Endocrinol Metab; 1978 Feb 01; 46(2):284-94. PubMed ID: 750606
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.